Evidence Based Medicine on FHIR Implementation Guide
1.0.0-ballot3 - STU 1 Ballot 3 World

Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 1.0.0-ballot3 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions

EvidenceVariable: OutcomeVariable: American Diabetes Association composite triple end point for metabolic control at 5 years

Computable Name:

version: 13; Last updated: 2023-12-06 21:24:16+0000

Profile: VariableDefinition

ArtifactPublicationStatus: Active

url: https://fevir.net/resources/EvidenceVariable/32143

identifier: FEvIR Object Identifier/32143

name: OutcomeVariable_American_Diabetes_Association_composite_triple_end_point_for_metabolic_control_at_5_years

title: OutcomeVariable: American Diabetes Association composite triple end point for metabolic control at 5 years

citeAs:

OutcomeVariable: American Diabetes Association composite triple end point for metabolic control at 5 years [EvidenceVariable]. Contributors: Brian S. Alper [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 32143. Revised 2022-05-28. Available at: https://fevir.net/resources/EvidenceVariable/32143. Computable resource at: https://fevir.net/resources/EvidenceVariable/32143.

status: Active

date: 2022-05-28 12:16:43+0000

author: Brian S. Alper:

publisher: Computable Publishing LLC

contact: support@computablepublishing.com

description:

The American Diabetes Association composite triple end point of hemoglobin A1c less than 7.0%, low-density lipoprotein cholesterol less than 100 mg/dL, and systolic blood pressure less than 130 mm Hg at 5 years

copyright:

https://creativecommons.org/licenses/by-nc-sa/4.0/

actual: true

Definitions

-Reference
*OutcomeDefinition: American Diabetes Association composite triple end point for metabolic control

handling: dichotomous variable